ESGO Prevention Webinars

ESGO Prevention 2

Established in 2019 to fulfil the ESGO vision: Best treatment and prevention in gynaecological cancer, the ESGO Prevention Committee connects more than 70 experts in vaccination, screening, colposcopy, and treatment of pre-invasive disease.

Apart from Prevention webinars, the Prevention Committee produces consensus statements on prevention-related topics. Visit the ESGO Prevention Committee website to learn more about the research we do.

Prof. Murat Gultekin chairs the Committee.

Joint ESGO, IPVS and ENTOG webinar:

IPVS December - Facebook

Colposcopy uncovered: Colposcopy Uncovered: Past, Present, and Future in Cervical Cancer Prevention and Innovation

December 10, 2025, 4 PM CET

  • Colposcopy. History, basic principles, setting, tools, technique - Vesna Kesic
  • The Role of ECC During Colposcopy - Mario Preti
  • Artificial Intelligence in Colposcopy. The PAVE project, phase 2 - Didem Egemen

Moderators: Murat Gultekin, Kimon Chatzistamatou

Panelist: Sara Vodopivec

Webinar abstract:

In this joint webinar together with IPVS and ENTOG, we explore the evolution of colposcopy, a cornerstone in cervical cancer prevention. Learn about its historical development, the key principles behind the procedure, and its vital role in today’s cervical cancer screening programs. Our expert speakers will dive into the ongoing advancements in colposcopy, including the integration of cutting-edge technologies like artificial intelligence, and how these innovations are shaping its future.

Oncogenetics in Focus: From Risk to Prevention in Women’s Cancers

November 11, 2025 7-8:30 PM CET

  • Lynch syndrome: endometrial and ovarian cancer risk - Claudia Marchetti
  • Which genetic tests and variants should be used for screening? - Angela George
  • Genetic and epigenetic variation in cervical preinvasive and invasive disease: Real-world implications - Sarah Bowden

Moderators: Mihaela Grigore, Murat Gultekin

Webinar abstract:

This webinar explored the evolving landscape of oncogenetics with a focus on genetic testing and its role in cancer risk assessment, prevention, and personalized care in gynecologic oncology. Experts discussed the latest advances in genetic screening, including the clinical application of BRCA and Lynch syndrome testing, as well as the emergence of new preventive testing kits now available on the market.

Beyond survival: Psycho-oncology, resilience, quality of life and sexuality after cancer

September 10, 2025 7-8:30 PM CET

  • Preserving quality of life in cancer patients - Houssein El Hajj
  • Can we prevent the long-term effects of treatment? - Elizabeth C. Branco
  • The role of resilience in the coping of patients and HCPs - Elisabeth Andritsch
  • From scars to connection, reclaiming sexual identity after cancer - Icó Tóth

Moderators: Annette Hasenburg, Murat Gultekin

Webinar abstract:

This webinar will focus on key aspects of psycho-oncology relevant to clinical practice, exploring how healthcare professionals can support and enhance the quality of life of cancer patients throughout the disease trajectory. Discussions will address whether long-term psychological and physical effects of treatment can be anticipated or prevented, and how early supportive interventions may impact survivorship.

HPV 360° - Innovations in Vaccination and Screening

July 9, 2025 7-8:30 PM CET

  • New trends in vaccination: single dose - Elmar Joura
  • New HPV vaccines on the market - Utku Akgor
  • New trends in screening - Alex Vorsters
  • High-risk HPV assays validated for screening - Marc Arbyn

Moderators: Rita Sousa, Murat Gultekin

Webinar abstract:

The session highlights newly available HPV vaccines and their potential impact, as well as the growing body of evidence supporting simplified vaccination schedules, including single-dose strategies. Speakers examine current trends in screening, such as risk-based approaches and the application of high-risk HPV assays that have been validated for primary screening. Special attention will be given to the validation principles required for HPV tests, and to assays that target a limited number of HPV types, exploring their potential role in future screening programs. This webinar offers a comprehensive overview for clinicians, researchers, and public health professionals interested in the evolving landscape of HPV prevention and control.

RECORDING: Virtual conference on cervical cancer elimination in Africa June 11, 2025

Session 1: Update on Cervical Cancer Prevention and Current Situation in Africa

Moderator: Jalid Sehouli

  • Murat Gultekin (Turkey),
  • Andreas Ullrich (Germany),
  • Mohamed Afifi (WHO EMRO),
  • David Atallah (MEMAGO),
  • Jalid Sehouli (PARSGO),
  • Hesham El Ghazaly (BGICS),
  • Dilyara Kaidarova (Cent-East),
  • Marc Arbyn (Belgium)
Cervical cancer conference

Session 2: New Trends in HPV Vaccines Focused on Africa

Moderator: Elmar Joura

  • Elmar Joura (Austria)
  • Laia Bruni (Spain)
  • Nelly Mugo (Kenya)
  • Anna Giuliano (USA)
  • Bhagyalaxmi Nayak (India)

Session 3: New trends in screening focused on Africa

Moderator: Murat Gultekin

  • Mario Poljak (Slovenia),
  • Nadja Taumberger (Austria),
  • Yalin Kilic (Turkey),
  • Basel Refky (Egypt),
  • Reda Hemida (Egypt),
  • Andreas Kaufmann (Germany),
  • Gabriel Reina (Spain),
  • Nina Dhollander (Belgium),
  • Mohammed Ezzet Charfi (Senegal),
  • Silvia De Sanjose (Spain),
  • Didem Egemen (USA),
  • Omar Gassama (Senegal)

Session 4: Colposcopy scenarios focused on Africa

Moderator: Mario Preti

  • Mihaela Grigore (Romania)
  • Vesna Kesic (Serbia)
  • Mario Preti (Italy)
  • Patrick Petignat (Switzerland)
  • Andre Boris Kind (Switzerland)
  • Mario Preti (Italy)
  • Didem Egemen (USA)

Session 5: Limited resource treatment focused on Africa

Moderator: Reda Hemida

  • David Cibula (CZ)
  • Maria Kyrgiou (UK)
  • Reda Hemida (Egypt), Rafik Barakat (Egypt)
  • Neamat Hegazy (Egypt)
  • Murat Gultekin (Turkey)

This is the second edition of a successful full-day virtual event that attracted 1300+ registered participants in 2024. It is focused on vaccination, screening, colposcopy, and treatment of pre-invasive disease in a limited-resource context.

Check out the programme for more details (available in PDF here):